Authors
Loading...
Novel multi-replicon incn-r plasmid contributes to drug resistance in escherichia coli, indicating urgent public health implications.
Sroithongkham et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: